179 related articles for article (PubMed ID: 26829843)
21. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
[TBL] [Abstract][Full Text] [Related]
22. Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder.
Khaled EM; Meguid NA; Bjørklund G; Gouda A; Bahary MH; Hashish A; Sallam NM; Chirumbolo S; El-Bana MA
Metab Brain Dis; 2016 Dec; 31(6):1419-1426. PubMed ID: 27406246
[TBL] [Abstract][Full Text] [Related]
23. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
24. Organ representation areas of different internal organs localized on the eyebrows & eyelids by the Bi-Digital O-Ring Test electromagnetic resonance phenomenon between 2 identical molecules--Part I: Detection of increased markers for cancer & heart disease from white hairs on the eyebrows and marked decrease in the markers after taking one optimal dose of DHEA.
Omura Y
Acupunct Electrother Res; 2008; 33(3-4):193-224. PubMed ID: 19301629
[TBL] [Abstract][Full Text] [Related]
25. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains.
Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA
Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307
[TBL] [Abstract][Full Text] [Related]
26. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.
Shin RW; Lee VM; Trojanowski JQ
J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898
[TBL] [Abstract][Full Text] [Related]
27. A new structured interview for children with autism spectrum disorder based on the DSM-IV.
Hansakunachai T; Roongpraiwan R; Sombuntham T; Limprasert P; Ruangdaraganon N
J Med Assoc Thai; 2014 Aug; 97 Suppl 8():S7-14. PubMed ID: 25518287
[TBL] [Abstract][Full Text] [Related]
28. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
Barage SH; Sonawane KD
Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
[TBL] [Abstract][Full Text] [Related]
29. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
[TBL] [Abstract][Full Text] [Related]
30. Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents.
Domingo JL
J Alzheimers Dis; 2006 Nov; 10(2-3):331-41. PubMed ID: 17119296
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
[TBL] [Abstract][Full Text] [Related]
32. Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue.
Ray B; Sokol DK; Maloney B; Lahiri DK
Sci Rep; 2016 May; 6():26052. PubMed ID: 27212113
[TBL] [Abstract][Full Text] [Related]
33. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR.
van Doorn LJ; Molijn A; Kleter B; Quint W; Colau B
J Clin Microbiol; 2006 Sep; 44(9):3292-8. PubMed ID: 16954263
[TBL] [Abstract][Full Text] [Related]
34. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
35. Molecular basis of Alzheimer's disease.
Gooch MD; Stennett DJ
Am J Health Syst Pharm; 1996 Jul; 53(13):1545-57; quiz 1603-4. PubMed ID: 8809275
[TBL] [Abstract][Full Text] [Related]
36. Different Populations of Human Locus Ceruleus Neurons Contain Heavy Metals or Hyperphosphorylated Tau: Implications for Amyloid-β and Tau Pathology in Alzheimer's Disease.
Pamphlett R; Kum Jew S
J Alzheimers Dis; 2015; 45(2):437-47. PubMed ID: 25547633
[TBL] [Abstract][Full Text] [Related]
37. [Tau protein and beta protein].
Nukina N
Nihon Ronen Igakkai Zasshi; 1990 May; 27(3):276-9. PubMed ID: 2120489
[TBL] [Abstract][Full Text] [Related]
38. Active full-length DNA Aβ
Rosenberg RN; Fu M; Lambracht-Washington D
Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
[TBL] [Abstract][Full Text] [Related]
39. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.
D'Andrea MR; Nagele RG
Curr Pharm Des; 2006; 12(6):677-84. PubMed ID: 16472157
[TBL] [Abstract][Full Text] [Related]
40. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.
VanItallie TB
Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
